文献速递功能神经外科小儿神经外科与脑积水

丘脑中央中核脑深部电刺激治疗Lennox-Gastaut综合征:系统综述与个体患者数据分析

Deep Brain Stimulation of the Centromedian Nucleus of the Thalamus for Lennox-Gastaut Syndrome: A Systematic Review and Individual Patient Data Analysis.
PubMed 文献 · Neurosurgery · 2022-12-30

该系统综述与个体患者数据分析纳入10项研究共114例患者,评估丘脑中央中核脑深部电刺激治疗Lennox-Gastaut综合征的疗效与安全性。6项报告≥50%发作减少的研究中多数显示≥50%患者达到该指标,发作无发作率一般<10%。个体数据分析显示38/41(80.9%)患者发作频率减少≥50%,仅3例(6.4%)达到无发作,作者认为有限数据显示该疗法可能有效且安全。

要点

  • 丘脑中央中核脑深部电刺激后80.9%(38/41)患者发作频率减少≥50%,仅6.4%(3/41)达到无发作。
  • 生活质量改善者占88.2%(30/34),并发症率为4.9%(2/41)。
  • 作者认为有限数据显示该疗法对Lennox-Gastaut综合征患者可能有效且安全。

核心结论

  • 有限数据显示丘脑中央中核脑深部电刺激对Lennox-Gastaut综合征患者可能有效且安全。

研究设计与样本

  • 按PRISMA指南检索PubMed、Embase和Scopus的系统综述与个体患者数据分析。
  • 最终纳入10项研究共114例患者,其中6项研究47例患者提供个体患者数据。

主要发现

  • 报告≥50%发作减少结局的7项研究中6项表明≥50%患者达到该指标并伴功能能力改善。
  • 无发作率一般<10%;个体数据中38/41(80.9%)患者发作频率减少≥50%,仅3例(6.4%)达到无发作。
  • 个体数据分析显示平均发作减少62.9%±31.2%,生活质量改善30/34(88.2%),无变化11.8%。
  • 个体数据分析显示并发症率2/41(4.9%),平均随访19.8±26.1个月(IQR:4-18个月)。
  • 个体数据分析显示癫痫起病平均年龄3.9±4.5岁,丘脑中央中核脑深部电刺激时平均年龄17.4±8.8岁;41例中19例(46.3%)MRI阳性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lennox-Gastaut syndrome (LGS) is a severe childhood-onset pharmacoresistant epilepsy. Deep brain stimulation (DBS) of the centromedian nucleus of the thalamus (CMN) has been utilized. OBJECTIVE: To conduct a systematic review and individual patient data (IPD) analysis to characterize outcomes of DBS of CMN in LGS. METHODS: PubMed, Embase, and Scopus were searched per Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Articles were screened by title/abstract then full text. Included articles were reviewed for bibliographic, demographic, and outcome data. IPD were extracted from studies providing IPD for all patients. RESULTS: Of 72 resultant articles, 10 studies (114 patients) were included. Six of 7 studies reporting the outcome of ≥50% seizure reduction indicated that ≥50% of patients achieved this, with improved functional ability. Seizure freedom rate was generally <10%. Six studies with 47 patients provided IPD. The mean ages at epilepsy onset and CMN DBS were 3.9 ± 4.5 years and 17.4 ± 8.8 years, respectively. Nineteen of 41 (46.3%) patients had positive MRI findings. Seizure types included atypical absence in 39 (83.0%) patients, generalized tonic-clonic in 32 (68.1%), tonic in 22 (46.8%), and atonic in 20 (42.6%). Thirty-eight (80.9%) patients experienced ≥50% reduction in seizure frequency, and only 3 (6.4%) experienced seizure freedom. The mean seizure reduction was 62.9% ± 31.2% overall. Quality of life improved in 30/34 (88.2%) and was unchanged in the remainder (11.8%). The complication rate was 2/41 (4.9%). The mean length of follow-up was 19.8 ± 26.1 months (IQR: 4-18 months). CONCLUSION: Limited data indicate that DBS of the CMN may be effective and safe for people with LGS.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Shlobin NA, Hofmann K, Cohen NT, et al. Deep Brain Stimulation of the Centromedian Nucleus of the Thalamus for Lennox-Gastaut Syndrome: A Systematic Review and Individual Patient Data Analysis. Neurosurgery. 2022. PMID: 36700706. doi:10.1227/neu.0000000000002280

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。